| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/05/2004 | WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | WO2004065540A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 08/05/2004 | WO2004065423A2 Recognition molecules for the treatment and detection of tumours |
| 08/05/2004 | WO2004065422A2 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065421A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065420A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065419A1 Antibody and use thereof |
| 08/05/2004 | WO2004065418A1 Anti-pci neutralizing antibody |
| 08/05/2004 | WO2004065417A2 Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
| 08/05/2004 | WO2004065416A2 Synthetic antibody phage libraries |
| 08/05/2004 | WO2004065409A2 Peptide mimotopes of lipooligosaccharide from nontypeable haemophilus influenzae as vaccines |
| 08/05/2004 | WO2004064857A1 Drugs containing galectin 9 |
| 08/05/2004 | WO2004064784A2 Composition and method for preventing or treating a virus infection |
| 08/05/2004 | WO2004064763A2 Cleavage of serum response factor in cardiac diagnosis and therapy |
| 08/05/2004 | WO2004064740A2 Sperm specific lysozyme-like proteins |
| 08/05/2004 | WO2004064724A2 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 08/05/2004 | WO2004046194A3 Polyclonal-monoclonal elisa assay for detecting n-terminus probnp |
| 08/05/2004 | WO2004043405A8 Polysaccharide vaccine for staphylococcal infections |
| 08/05/2004 | WO2004040262A3 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 08/05/2004 | WO2004033645A3 Methods of regulating body weight |
| 08/05/2004 | WO2004029622A3 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004022770A3 Compositions and methods for synthesizing nucleic acids |
| 08/05/2004 | WO2004009615A3 Cd40-ligand lacking native-pattern glycosylation |
| 08/05/2004 | WO2004000238A3 Utilization of mhc class ii binding motifs in immunization to produce immune serum, monoclonal antibodies and vaccines |
| 08/05/2004 | WO2003054550A8 Uses of an endothelial cell receptor |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003024191A3 Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof |
| 08/05/2004 | US20040154044 Transgenic cell and animal modeling ige-mediated human allergic responses and use thereof |
| 08/05/2004 | US20040152873 Novel gene bn01 mapping to chromosone 16q24.3 |
| 08/05/2004 | US20040152872 by using pairs of side chains to stabilize or to form pH-dependent molecular switches; genetic engineering |
| 08/05/2004 | US20040152870 Comprises protein on surface of specialized connective tissue for use in identifying modulator for treatments for allergic diseases |
| 08/05/2004 | US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus |
| 08/05/2004 | US20040152638 Protegrins |
| 08/05/2004 | US20040152170 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| 08/05/2004 | US20040152169 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
| 08/05/2004 | US20040152164 62 human secreted proteins |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152144 Novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152131 Methods for end point temperature testing |
| 08/05/2004 | US20040152125 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |
| 08/05/2004 | US20040152115 directed toward modulating oxidative damage to intracellular components such as mitochondrial DNA (mtDNA) and mitochondrial protein |
| 08/05/2004 | US20040152103 by co-expressing polypeptides using escherichia coli; immunoglobulins; single chain FV fragments; genetic engineering |
| 08/05/2004 | US20040152095 delta-like (dlk) specifically expressed on the surfaces of fetal hepatic cells; for assay/screening systems for drug metabolism and hepatitis viruses proliferation/infection models |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | US20040151727 isolated or recombinant YscF protein that confers protection against a pathogen of a Yersinia origin; nucleic acid that encodes it; transformed cells and vaccines |
| 08/05/2004 | US20040151724 Antibody fab fragments specific for breast cancer |
| 08/05/2004 | US20040151722 Treatment of metabolic disorders using TNFalpha inhibitors |
| 08/05/2004 | US20040151721 Humanized anti-CCR2 antibodies and methods of use therefor |
| 08/05/2004 | US20040151720 Cell surface molecule mediating cell adhesion and signal transmission |
| 08/05/2004 | US20040151717 Use of polyclonal immunoglobulins |
| 08/05/2004 | US20040151712 Modulation of inflammation related to columnar epithelia |
| 08/05/2004 | US20040151692 administering a substance that can activate CD163 to stimulate the growth, proliferation, differentiation and/or mobilization of a stem cell, e.g., a substance that binds CD163 includes antibodies and CD163 ligands. |
| 08/05/2004 | US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens |
| 08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
| 08/05/2004 | US20040151665 Scrrening; separation using cancer cell cytotoxicity; diagnosis, antitumor agents, anticancer agents; administering monoclonal antibodies |
| 08/05/2004 | DE202004006867U1 Kohlenstoffbasierte Formkörper geeignet zur Verwendung als Zellkulturträger- und Aufzuchtsysteme Carbon-based molding suited for use as Zellkulturträger- and rearing systems |
| 08/05/2004 | DE10303974A1 Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung Amyloid-β (1-42) oligomers, processes for their preparation and their use |
| 08/05/2004 | CA2648056A1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 08/05/2004 | CA2517469A1 .beta.1,3-n-acetyl-d-galactosaminyltransferase protein and nucleic acid encoding the same, as well as canceration assay using the same |
| 08/05/2004 | CA2514153A1 Antibody and use thereof |
| 08/05/2004 | CA2514108A1 Drugs containing galectin 9 |
| 08/05/2004 | CA2514052A1 Activation and expansion of t cells |
| 08/05/2004 | CA2513797A1 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 08/05/2004 | CA2513772A1 Cancerous disease modifying antibodies |
| 08/05/2004 | CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | CA2513113A1 Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
| 08/05/2004 | CA2511570A1 Composition and method for preventing or treating a virus infection |
| 08/05/2004 | CA2510003A1 Synthetic antibody phage libraries |
| 08/04/2004 | EP1443111A1 Desmin gene having novel point mutation causative of dilated cardiomyopathy |
| 08/04/2004 | EP1442749A1 Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system |
| 08/04/2004 | EP1442295A2 Periostin-based diagnostic assays |
| 08/04/2004 | EP1442132A2 Methods for the treatment of osteoarthritis and compositions thereof |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442063A2 Anti-n-glycolyl-neuraminic acid antibodies and their use for identifying glycoproteins |
| 08/04/2004 | EP1442062A2 Methods for the treatment of carcinoma |
| 08/04/2004 | EP1442061A1 Reducing immunogenicities of immunoglobulins by framework-patching |
| 08/04/2004 | EP1442060A2 A novel g protein-coupled receptor, gave 10 |
| 08/04/2004 | EP1442046A2 Mammalian c-type lectins |
| 08/04/2004 | EP1441766A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 08/04/2004 | EP1441765A2 Method for preparation of single chain antibodies |
| 08/04/2004 | EP1441764A2 Antigen arrays comprising rankl for treatment of bone disease |
| 08/04/2004 | EP1441589A2 Stable liquid pharmaceutical formulation of igg antibodies |
| 08/04/2004 | EP1384075A4 Methods of detecting early renal disease in animals |
| 08/04/2004 | EP1285054B1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 08/04/2004 | EP1133564B1 Zace1: a human metalloenzyme |
| 08/04/2004 | EP1034001B1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/04/2004 | EP1029246B1 A method and device for preventing immunoglobulin degradation in external secretions |
| 08/04/2004 | EP1012577A4 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus |